Trimetazidine – Cardiology MCQ
Trimetazidine is an antianginal agent which acts by inhibition of:
A. Beta oxidation of fatty acids
B. Anaerobic metabolism of glucose
C. Calcium channels
D. Beta adrenergic receptors
Please check the YouTube video above for discussion
Related Posts
-
Surgical embolectomy in pulmonary embolism – Cardiology MCQ
No Comments | Sep 3, 2016 -
Cardiac CT – Cardiology MCQ
No Comments | Nov 5, 2015 -
Orthostatic challenge – Cardiology MCQ
No Comments | Apr 29, 2018 -
Causative agent of rheumatic fever – Cardiology MCQ
No Comments | Sep 2, 2013
About The Author
Johnson Francis
Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal